Skip to main content

Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry

Published: 27 June 2017

A study published on the Respiratory Medicine Journal investigates the need for additional research on smokers with respiratory symptoms (dyspnoea, cough, or sputum production) and normal spirometry.

The purpose of this study was to evaulate whether symptomatic smokers with borderline spirometry (post-bronchodilator FEV1/FVC ratio between 5th to 20th percentile of predicted values) have pulmonary function abnormalities at rest and ventilatory constraints during exercise.

48 subjects (aged 60 ± 8 years, mean ± SD, 73% males, 16 healthy, and 17 symptomatic smokers) underwent cardiopulmonary exercise testing (CPET), body plethysmography, nitrogen singlebreath washout test (N2SBW), lung diffusion for carbon monoxide (DLCO), and forced oscillation technique (FOT).

In presence of respiratory symptoms not fully explained by spirometry, a careful diagnostic approach requires second line tests. Indeed, without a diagnosis it is impossible to prescribe the right therapy, schedule a correct follow-up, and postulate a prognosis. In our study CPET and second line pulmonary function tests revealed an obstructive pattern in symptomatic smokers undetected at spirometry.Whether the natural history of these patients is similar to COPD, and they deserve a similar therapeutic approach is worth investigating. Without a clear demonstration of long-term benefit of bronchodilators in patients with normal spirometry and an obstructive pattern at second-level pulmonary function tests, a strict follow-up appears the current most reasonable approach.

The article details are the following:

Title: "Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry"
Authors: Di Marco F, Terraneo S, Job S, Rinaldo RF, Sferrazza Papa GF, Roggi MA, Santus P, Centanni S
- Published in
: Respir Med. 2017 Jun;127:7-13

The study can be purchased at the following link: click here

Get in touch

COSMED strives to provide the best service possible with every contact!

Fill the online forms to get the info you're looking for right now!

Register your Product

Register your Product

Fill the online form to get software upgrades and more advantages

Read more

Request for information

Request for information

Fill the online form to get more information or a quote 

Read more

Request for Support

Request for Support

Fill the online form in order to help us fully understand your problem

Read more

COSMED LOGO
COSMED LOGO

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

FOLLOW US ON

FOLLOW US ON